检索结果 - Shirish M. Gadgeel
- Showing 1 - 20 results of 104
- Go to Next Page
-
1
-
2
Racial differences in lung cancer. 由 Shirish M. Gadgeel, Gregory P. Kalemkerian
出版 2003Revisão -
3
Modern Staging of Small Cell Lung Cancer 由 Gregory P. Kalemkerian, Shirish M. Gadgeel
出版 2013Artigo -
4
-
5
-
6
-
7
-
8
Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor, in Patients with Platinu... 由 Shirish M. Gadgeel, John C. Ruckdeschel, Elisabeth I. Heath, Lance K. Heilbrun, Raghu Venkatramanamoorthy, Antoinette J. Wozniak
出版 2007Artigo -
9
-
10
-
11
-
12
-
13
-
14
Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival 由 Jennifer Beebe‐Dimmer, Jon P. Fryzek, Cecilia Yee, Tapashi Dalvi, David H. Garabrant, Ann G. Schwartz, Shirish M. Gadgeel
出版 2016Artigo -
15
-
16
Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data 由 Priscila Gonçalves, Stephanie Peterson, Fawn D. Vigneau, Ronald Shore, William Quarshie, Khairul Islam, Ann G. Schwartz, Antoinette J. Wozniak, Shirish M. Gadgeel
出版 2016Artigo -
17
-
18
Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials 由 Julien Mazières, Achim Rittmeyer, Shirish M. Gadgeel, Toyoaki Hida, David R. Gandara, Diego Cortinovis, Fabrice Barlési, Wei Yu, Christina Matheny, Marcus Ballinger, Keunchil Park
出版 2020Artigo -
19
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow... 由 Shirish M. Gadgeel, Delvys Rodríguez‐Abreu, Balázs Halmos, Marina Chiara Garassino, Takayasu Kurata, Ying Cheng, Erin Jensen, Mark Shamoun, Kumar Rajagopalan, Luis Paz‐Ares
出版 2024Artigo -
20
Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer 由 Vinita Singh‐Gupta, Michael C. Joiner, L. Runyan, Christopher K. Yunker, Fazlul H. Sarkar, Stephen R. Miller, Shirish M. Gadgeel, André Konski, Gilda G. Hillman
出版 2011Artigo
相关主题
Medicine
Internal medicine
Oncology
Cancer
Lung cancer
Chemotherapy
Immunotherapy
Biology
Pembrolizumab
Adverse effect
Cancer research
Confidence interval
Gastroenterology
Clinical endpoint
Clinical trial
Epidermal growth factor receptor
Hazard ratio
Cisplatin
Genetics
Pemetrexed
Cohort
Environmental health
Gene
Population
Phases of clinical research
Crizotinib
Malignant pleural effusion
Pathology
Pharmacology
Surgery